Gender difference of serum angiotensin-converting enzyme (ACE) activity in DD genotype of ACE insertion/deletion polymorphism in elderly Chinese

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 15, Issue 4, 2014, Pages 547-552

  Zhang, Ya Feng ^a,b   Cheng, Qiong ^a   Tang, Nelson L S ^b   Chu, Tanya T W ^b   Tomlinson, Brian ^b   Liu, Fan ^a   Kwok, Timothy C Y ^b  

^a NANTONG UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Angiotensin converting enzyme; gender difference; insertion deletion polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

AGED; ARTICLE; CHINESE; CONTROLLED STUDY; DD GENOTYPE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HONG KONG; HUMAN; INDEL MUTATION; MALE; POLYMERASE CHAIN REACTION; SEX DIFFERENCE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CHINA; GENE FREQUENCY; GENETICS; SEXUAL DEVELOPMENT;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INDEL MUTATION; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; SEX CHARACTERISTICS;

EID: 84918516715     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320313475906     Document Type: Article

References (38)

1. Erdös EG, Skidgel RA. The angiotensin I-converting enzyme. Lab Invest. 1987 ; 56: 345-348
2. Jaspard E, Wei L, Alhenc-Gelas F. Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides. J Biol Chem. 1993 ; 268: 9496-9503
3. Ramchandran R, Sen GC, Misono K, et al. Regulated cleavage-secretion of the membrane-bound angiotensin-converting enzyme. J Biol Chem. 1994 ; 269: 2125-2130
4. Esther CR, Howard TE, Marino EM, et al. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest. 1996 ; 74: 953-965
5. Parmley WW. Evolution of angiotensin-converting enzyme inhibition in hypertension, heart failure, and vascular protection. Am J Med. 1998 ; 105: 27S - 31S
6. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics - 2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008 ; 117: e25 - e146
7. Cambien F, Alhenc-Gelas F, Herbeth B, et al. Familial resemblance of plasma angiotensin-converting enzyme level: The Nancy Study. Am J Hum Genet. 1988 ; 43: 774-780
8. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990 ; 86: 1343-1346
9. Wong TY, Szeto CC, Chow KM, et al. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy. Am J Kidney Dis. 2001 ; 38: 9-17
10. Sayed-Tabatabaei FA, Houwing-Duistermaat JJ, van Duijn CM, et al. Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: A meta-analysis. Stroke. 2003 ; 34: 1634-1639
11. Schwartz GL, Turner ST, Chapman AB, et al. Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide. Kidney Int. 2002 ; 62: 1718-1723
12. Lau EM, Leung PC, Kwok T, et al. The determinants of bone mineral density in Chinese men - results from Mr Os (Hong Kong), the first cohort study on osteoporosis in Asian men. Osteoporos Int. 2006 ; 17: 297-303
13. Lynn H, Kwok T, Wong SY, et al. Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone. 2006 ; 38: 584-588
14. So WY, Ma RC, Ozaki R, et al. Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients - interaction with ACE insertion/deletion polymorphism. Kidney Int. 2006 ; 69: 1438-1443
15. Chan KC, Tang NL, Hui DS, et al. Absence of association between angiotensin converting enzyme polymorphism and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome: A case control study. BMC Infect Dis. 2005 ; 5: 26
16. Adamzik M, Frey U, Sixt S, et al. ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS. Eur Respir J. 2007 ; 29: 482-488
17. Kruit A, Grutters JC, Gerritsen WB, et al. ACE I/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis. Respir Med. 2007 ; 101: 510-515
18. Kario K, Hoshide S, Umeda Y, et al. Angiotensinogen and angiotensin-converting enzyme genotypes, and day and night blood pressures in elderly Japanese hypertensives. Hypertens Res. 1999 ; 22: 95-103
19. Giner V, Poch E, Bragulat E, et al. Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension. Hypertension. 2000 ; 35: 512-517
20. Schunkert H, Hense HW, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994 ; 330: 1634-1638
21. Castellano M, Glorioso N, Cusi D, et al. Genetic polymorphism of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: The GENIPER Project. J Hypertens. 2003 ; 21: 1853-1860
22. Agarwal A, Williams GH, Fisher ND. Genetics of human hypertension. Trends Endocrinol Metab. 2005 ; 16: 127-133
23. Sayed-Tabatabaei FA, Houwing-Duistermaat JJ, van Duijn CM, et al. Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: A meta-analysis. Stroke. 2003 ; 34: 1634-1639
24. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992 ; 359: 641-644
25. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, et al. ACE gene polymorphism: Ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation. 1997 ; 95: 2358-2367
26. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A. ACE gene polymorphism in cardiovascular disease: Meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol. 2000 ; 20: 484-492
27. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, et al. ACE polymorphisms. Circ Res. 2006 ; 98: 1123-1133
28. Lim YK, Retnam L, Bhagavath B, et al. Gonadal effects on plasma ACE activity in mice. Atherosclerosis. 2002 ; 160: 311-316
29. Sullivan JC, Semprun-Prieto L, Boesen EI, et al. Sex and sex hormones influence the development of albuminuria and renal macrophage infiltration in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2007 ; 293: R1573 - R1579
30. Biller H, Zissel G, Ruprecht B, et al. Genotype-corrected reference values for serum angiotensin-converting enzyme. Eur Respir J. 2006 ; 28: 1085-1090
31. Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med. 1975 ; 59: 365-372
32. Lieberman J, Schleissner LA, Nosal A, et al. Clinical correlations of serum angiotensin-converting enzyme (ACE) in sarcoidosis. A longitudinal study of serum ACE, 67gallium scans, chest roentgenograms, and pulmonary function. Chest. 1983 ; 84: 522-528
33. Ribichini F, Steffenino G, Dellavalle A, et al. Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: A major risk factor and a marker of risk for coronary stent restenosis. Circulation. 1998 ; 97: 147-154
34. Paolisso G, Tagliamonte MR, De Lucia D, et al. ACE gene polymorphism and insulin action in older subjects and healthy centenarians. J Am Geriatr Soc. 2001 ; 49: 610-614
35. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group. Am J Med. 1991 ; 90: 450-459
36. Diamond MP, Jones T, Caprio S, et al. Gender influences counterregulatory hormone responses to hypoglycemia. Metabolism. 1993 ; 42: 1568-1572
37. Amiel SA, Maran A, Powrie JK, et al. Gender differences in counterregulation to hypoglycaemia. Diabetologia. 1993 ; 36: 460-464
38. Pedersen-Bjergaard U, Dhamrait SS, Sethi AA, et al. Genetic variation and activity of the renin-angiotensin system and severe hypoglycemia in type 1 diabetes. Am J Med. 2008 ; 121: 246.e1-8